Hippotherapy Teenager-pediatric Radiotherapy
ConditionRadiotherapy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-17
SponsorCentre Paul Strauss
About this trial
This study proposes a horse-assisted therapy (HAT) approach to accompany children and young adults undergoing irradiation in the ICANS Radiotherapy Department.
The aim of this new approach is to improve quality of life and reduce anxiety in children and adolescents treated with radiotherapy. The impact of equine-assisted therapy on quality of life and anxiety disorders will be described prospectively between the start and end of irradiation in children and parents who agree to inclusion.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Children aged 8 to <18 years.
With an indication for radiotherapy for cancer (of any type)
Patients hospitalized and/or managed on an ambulatory basis
WHO ≤ 2
Disqualifiers
Children afraid of horses and stables
Contraindication to the practice of equine-assisted therapy (allergy to horses or dust, children with asthma attacks triggered by dust/animal hair ...)
Patient on stretcher
Children or parents (or carers) with significant cognitive impairment, making self-assessment or hetero-assessment impossible even with assistance
Trial design
Design model
Single group
Treatments tested in this trial
Participation in 10 horse-assisted therapy sessions
Other interventionsupporting children and teenagers undergoing radiotherapy with a horse-assisted therapy approach
Treatment groups
22 Participants
are divided into 1 treatment groupGroup A: entire study populationOther 1 intervention
Trial outcomes
Primary outcomes
1
Evolution of quality of life between the beginning and the end of horse-assisted therapy (HAT) in children (self-questionnaire) treated with radiotherapy
The questionnaire used to assess quality of life will be completed by the child. Two versions of the VSP-A questionnaire exist, depending on the child's age (versions \< 10 years and 10-17 years). Results can be compared with reference values for the general population.
Time frame
before radiotherapy, halfway through the HAT sessions (at 5 weeks), at the end of the HAT sessions (at 10 weeks) and one month after the end of the HAT sessionsSecondary outcomes
1
Improving children's quality of life between the start and end of irradiation (hetero-questionnaire) by HAT
Parents (or carers) will complete a questionnaire to assess their child's quality of life.
Time frame
before radiotherapy, halfway through the HAT sessions (at 5 weeks), at the end of the HAT sessions (at 10 weeks) and one month after the end of the HAT sessions2
Decrease anxiety disorders between the beginning - child version and end of irradiation in children (self-questionnaire) with HAT
The questionnaire used to assess anxiety will be completed by the child (SCARED child version)
Time frame
before radiotherapy, halfway through HAT sessions (at 5 weeks), at the end of HAT sessions (at 10 weeks) and one month after the end of HAT sessions3
Decrease anxiety disorders between the beginning - parents' version and end of irradiation in children (self-questionnaire) with HAT
Parents (or carers) will also complete a questionnaire to assess their child's anxiety (SCARED parents' version)
Time frame
before radiotherapy, halfway through HAT sessions (at 5 weeks), at the end of HAT sessions (at 10 weeks) and one month after the end of HAT sessions4
Assessing the acute side effects of radiotherapy at the start and end of irradiation
Evaluation of acute toxicities induced by radiotherapy CTCAE version 5 scale
Time frame
at the start and end of radiotherapy sessions (from 3 to 7 weeks)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov